Cargando…

Evaluating the Clinical Validity of Hypertrophic Cardiomyopathy Genes

BACKGROUND: Genetic testing for families with hypertrophic cardiomyopathy (HCM) provides a significant opportunity to improve care. Recent trends to increase gene panel sizes often mean variants in genes with questionable association are reported to patients. Classification of HCM genes and variants...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ingles, Jodie, Goldstein, Jennifer, Thaxton, Courtney, Caleshu, Colleen, Corty, Edward W., Crowley, Stephanie B., Dougherty, Kristen, Harrison, Steven M., McGlaughon, Jennifer, Milko, Laura V., Morales, Ana, Seifert, Bryce A., Strande, Natasha, Thomson, Kate, Peter van Tintelen, J., Wallace, Kathleen, Walsh, Roddy, Wells, Quinn, Whiffin, Nicola, Witkowski, Leora, Semsarian, Christopher, Ware, James S., Hershberger, Ray E., Funke, Birgit
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6410971/ https://www.ncbi.nlm.nih.gov/pubmed/30681346 http://dx.doi.org/10.1161/CIRCGEN.119.002460

Ejemplares similares

Adaptation and validation of the ACMG/AMP variant classification framework for MYH7-associated inherited cardiomyopathies: recommendations by ClinGen’s Inherited Cardiomyopathy Expert Panel
por: Kelly, Melissa A, et al.
Publicado: (2018)

Development of a communication aid for explaining hypertrophic cardiomyopathy genetic test results
por: Smagarinsky, Yana, et al.
Publicado: (2017)

Physical activity in hypertrophic cardiomyopathy: prevalence of inactivity and perceived barriers
por: Sweeting, Joanna, et al.
Publicado: (2016)

Evaluating a custom-designed aid to improve communication of genetic results in families with hypertrophic cardiomyopathy: study protocol for a randomised controlled trial
por: Burns, Charlotte, et al.
Publicado: (2019)

International Evidence Based Reappraisal of Genes Associated With Arrhythmogenic Right Ventricular Cardiomyopathy Using the Clinical Genome Resource Framework
por: James, Cynthia A., et al.
Publicado: (2021)

Molecular autopsy in victims of inherited arrhythmias
por: Semsarian, Christopher, et al.
Publicado: (2016)

Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy
por: Marston, Nicholas A, et al.
Publicado: (2021)

Sex Differences in Hypertrophic Cardiomyopathy: Interaction With Genetics and Environment
por: Butters, Alexandra, et al.
Publicado: (2021)

Routinely collected health data to study inherited heart disease: a systematic review (2000–2016)
por: Blanch, Bianca, et al.
Publicado: (2017)

Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction: Insights From the SHaRe Registry
por: Marstrand, Peter, et al.
Publicado: (2020)

Harmonizing the Collection of Clinical Data on Genetic Testing Requisition Forms to Enhance Variant Interpretation in Hypertrophic Cardiomyopathy (HCM): A Study from the ClinGen Cardiomyopathy Variant Curation Expert Panel
por: Morales, Ana, et al.
Publicado: (2021)

Neutrophil Caspase-11 Is Essential to Defend against a Cytosol-Invasive Bacterium
por: Kovacs, Stephen B., et al.
Publicado: (2020)

Evidence-Based Assessment of Genes in Dilated Cardiomyopathy
por: Jordan, Elizabeth, et al.
Publicado: (2021)

Needs analysis of parents following sudden cardiac death in the young
por: McDonald, Kristie, et al.
Publicado: (2020)

Determining the clinical validity of hereditary colorectal cancer and polyposis susceptibility genes using the Clinical Genome Resource Clinical Validity Framework
por: Seifert, Bryce A., et al.
Publicado: (2018)

Computational prediction of protein subdomain stability in MYBPC3 enables clinical risk stratification in hypertrophic cardiomyopathy and enhances variant interpretation
por: Thompson, Andrea D., et al.
Publicado: (2021)

Exercise restrictions trigger psychological difficulty in active and athletic adults with hypertrophic cardiomyopathy
por: Luiten, Rebecca C, et al.
Publicado: (2016)

Exome sequencing identifies a novel mutation in the MYH6 gene in a family with early-onset sinus node dysfunction, ventricular arrhythmias, and cardiac arrest()
por: Lam, Lien, et al.
Publicado: (2015)

LAMP2 shines a light on cardiomyopathy in an athlete
por: Martin, Sophie, et al.
Publicado: (2017)

Spatial and Functional Distribution of MYBPC3 Pathogenic Variants and Clinical Outcomes in Patients With Hypertrophic Cardiomyopathy
por: Helms, Adam S., et al.
Publicado: (2020)

New Variant With a Previously Unrecognized Mechanism of Pathogenicity in Hypertrophic Cardiomyopathy
por: Aguib, Yasmine, et al.
Publicado: (2021)

Rare desmin variant causing penetrant life-threatening arrhythmic cardiomyopathy
por: Oomen, Ad W.G.J., et al.
Publicado: (2018)

Defining the genetic architecture of hypertrophic cardiomyopathy: re-evaluating the role of non-sarcomeric genes
por: Walsh, Roddy, et al.
Publicado: (2017)

Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic Cardiomyopathy During Childhood: Insights From the SHaRe Registry
por: Abou Alaiwi, Sarah, et al.
Publicado: (2023)

Getting inside the engine - myosin modulation in hypertrophic cardiomyopathy and systolic heart failure
por: Daniels, Matthew J, et al.
Publicado: (2021)

Using high-resolution variant frequencies to empower clinical genome interpretation
por: Whiffin, Nicola, et al.
Publicado: (2017)

Clinical and genetic features of Australian families with long QT syndrome: A registry-based study
por: Burns, Charlotte, et al.
Publicado: (2016)

Beyond gene-disease validity: capturing structured data on inheritance, allelic-requirement, disease-relevant variant classes, and disease mechanism for inherited cardiac conditions
por: Josephs, Katherine S, et al.
Publicado: (2023)

Beyond gene-disease validity: capturing structured data on inheritance, allelic requirement, disease-relevant variant classes, and disease mechanism for inherited cardiac conditions
por: Josephs, Katherine S., et al.
Publicado: (2023)

External validation of the HCM Risk-Kids model for predicting sudden cardiac death in childhood hypertrophic cardiomyopathy
por: Norrish, Gabrielle, et al.
Publicado: (2021)

Using codesign focus groups to develop an online COmmunity suPporting familiEs after Sudden Cardiac Death (COPE-SCD) in the young
por: Yeates, Laura, et al.
Publicado: (2022)

Global MicroRNA Profiling of the Mouse Ventricles during Development of Severe Hypertrophic Cardiomyopathy and Heart Failure
por: Bagnall, Richard D., et al.
Publicado: (2012)

Truncating Variants in Titin Independently Predict Early Arrhythmias in Patients With Dilated Cardiomyopathy
por: Tayal, Upasana, et al.
Publicado: (2017)

Phenotypic Expression and Outcomes in Individuals With Rare Genetic Variants of Hypertrophic Cardiomyopathy
por: de Marvao, Antonio, et al.
Publicado: (2021)

Ventricular fibrillation and sudden cardiac arrest in apical hypertrophic cardiomyopathy: Two case reports
por: Park, Yae Min, et al.
Publicado: (2021)

Presence Of Left Ventricular Non Compaction In Hypertrophic Cardiomyopathy Is Associated With Arrhythmia
por: Gnanappa, Ganesh Kumar, et al.
Publicado: (2016)

Genotype and Lifetime Burden of Disease in Hypertrophic Cardiomyopathy: Insights From the Sarcomeric Human Cardiomyopathy Registry (SHaRe)
por: Ho, Carolyn Y., et al.
Publicado: (2018)

Quantitative approaches to variant classification increase the yield and precision of genetic testing in Mendelian diseases: the case of hypertrophic cardiomyopathy
por: Walsh, Roddy, et al.
Publicado: (2019)

The Australian Genetic Heart Disease Registry: Protocol for a Data Linkage Study
por: Butters, Alexandra, et al.
Publicado: (2023)

Patients With Genetic Heart Disease and COVID-19: A Cardiac Society of Australia and New Zealand (CSANZ) Consensus Statement
por: Gray, Belinda, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7t7j2498f3g62fet71ib6qr41c